NCT05479136View on ClinicalTrials.gov

18F-Fluciclovine PET Imaging for Detecting High Grade Glioma Recurrence After Radiochemotherapy

PHASE3UnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 24, 2022

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
Grade III or Grade IV Glioma
Interventions
DRUG

PET imaging with 18F fluciclovine

PET with 18F fluciclovine injection, 185 MBq (5 mCi) ± 20%, delivered as an intravenous bolus

Trial Locations (1)

85013

RECRUITING

Barrow Neurological Institute at St. Joseph's Hospital and Medical Center, Phoenix

Sponsors

Collaborators (1)

Blue Earth Diagnostics
All Listed Sponsors
collaborator

Blue Earth Diagnostics

INDUSTRY

collaborator

Barrow Neurological Foundation

OTHER

lead

Nicole Hill

OTHER

NCT05479136 - 18F-Fluciclovine PET Imaging for Detecting High Grade Glioma Recurrence After Radiochemotherapy | Biotech Hunter | Biotech Hunter